Literature DB >> 31236682

Clinical and radiographic evaluation of bioactive glass in posterior cervical and lumbar spinal fusion.

Cédric Barrey1, Théo Broussolle2.   

Abstract

INTRODUCTION: Spinal surgery of degenerative painful segments is a valuable treatment option in the management of chronic cervical and low back pain. The surgery consists in stabilizing and fusing painful vertebral segment(s). The objective of the study was to report our experience with 45S5 bioactive glass (BAG) to obtain inter-vertebral fusion in the context of posterior spine surgery. MATERIAL AND
METHOD: In this retrospective study, 30 patients with a wide range of degenerative and traumatic conditions of the cervical or lumbar spine underwent spinal fusion utilizing a synthetic bone graft substitute of BAG (GlassBone™, Noraker, Lyon-Villeurbanne, France). The pain was evaluated by VAS score, and graft consolidation was assessed on according radiographic images at 1-year post-op.
RESULTS: All patients underwent posterior spinal fusion either in the cervical or the thoraco-lumbar spine. Multi-level fusions represented the majority of the cohort (43% of patients with more than seven levels treated). Radiographic imaging demonstrated excellent fusion rates (93%) at final follow-up, equivalent to the outcomes reported in the literature for autogenous bone, with excellent bone bridging and no spinal implant loosening. Only two cases of non-union were encountered. Additionally, 90% of the patients demonstrated recovery at 1 year after surgery with a pain reduction of 60%.
CONCLUSION: The results of this retrospective study suggest that the 45S5 BAG may be an interesting alternative option to autologous graft, in terms of safety and bone fusion efficiency. LEVEL OF EVIDENCE: IV Retrospective study.

Entities:  

Keywords:  Bioactive glass; Bone graft; Spinal fusion; Spinal surgery

Mesh:

Substances:

Year:  2019        PMID: 31236682     DOI: 10.1007/s00590-019-02477-5

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  20 in total

1.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution.

Authors:  I D Xynos; A J Edgar; L D Buttery; L L Hench; J M Polak
Journal:  J Biomed Mater Res       Date:  2001-05

2.  Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis.

Authors:  I D Xynos; A J Edgar; L D Buttery; L L Hench; J M Polak
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

Review 3.  Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute.

Authors:  Scott D Boden
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

4.  [Complications of surgical treatment of spinal deformities: a prospective multicentric study of 3311 patients].

Authors:  P Guigui; A Blamoutier
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  2005-06

5.  A prospective randomized study of unilateral versus bilateral instrumented posterolateral lumbar fusion in degenerative spondylolisthesis.

Authors:  Mariano Fernández-Fairen; Pedro Sala; Hernán Ramírez; Javier Gil
Journal:  Spine (Phila Pa 1976)       Date:  2007-02-15       Impact factor: 3.468

6.  Particulate bioglass compared with hydroxyapatite as a bone graft substitute.

Authors:  H Oonishi; S Kushitani; E Yasukawa; H Iwaki; L L Hench; J Wilson; E Tsuji; T Sugihara
Journal:  Clin Orthop Relat Res       Date:  1997-01       Impact factor: 4.176

7.  Surgical site infection in spinal surgery: description of surgical and patient-based risk factors for postoperative infection using administrative claims data.

Authors:  Amir Abdul-Jabbar; Steven Takemoto; Michael H Weber; Serena S Hu; Praveen V Mummaneni; Vedat Deviren; Christopher P Ames; Dean Chou; Philip R Weinstein; Shane Burch; Sigurd H Berven
Journal:  Spine (Phila Pa 1976)       Date:  2012-07-01       Impact factor: 3.468

8.  The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion.

Authors:  Wen-Jer Chen; Tsung-Ting Tsai; Lih-Huei Chen; Chi-Chien Niu; Po-Liang Lai; Tsai-Sheng Fu; Kevin McCarthy
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-15       Impact factor: 3.468

9.  Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient.

Authors:  Frank P Cammisa; Gary Lowery; Steven R Garfin; Fred H Geisler; Peter M Klara; Robert A McGuire; Walter R Sassard; Harrison Stubbs; Jon E Block
Journal:  Spine (Phila Pa 1976)       Date:  2004-03-15       Impact factor: 3.468

10.  ACDF Graft Selection by Surgeons: Survey of AOSpine Members.

Authors:  S Tim Yoon; Jeffrey A Konopka; Jeffrey C Wang; Jim A Youssef; Hans Joerg Meisel; Darrel S Brodke; Jong-Beom Park
Journal:  Global Spine J       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.